{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:05:13Z","timestamp":1790910313118,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010226","name":"Guangdong Provincial Department of Education","doi-asserted-by":"crossref","award":["1JG23006"],"award-info":[{"award-number":["1JG23006"]}],"id":[{"id":"10.13039\/501100010226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02757-3","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T01:55:27Z","timestamp":1751853327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["IFN\u03b1\u2013IFITM1\u2013ERK axis in corneal epithelial cell damage: implications for dry eye disease"],"prefix":"10.1186","volume":"30","author":[{"given":"Hongjuan","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"2757_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2147\/OPTH.S188314","volume":"13","author":"JL Bradley","year":"2019","unstructured":"Bradley JL, et al. Dry eye disease ranking among common reasons for seeking eye care in a large US claims database. Clin Ophthalmol. 2019;13:225\u201332.","journal-title":"Clin Ophthalmol"},{"key":"2757_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108294","volume":"201","author":"VL Perez","year":"2020","unstructured":"Perez VL, Stern ME, Pflugfelder SC. Inflammatory basis for dry eye disease flares. Exp Eye Res. 2020;201: 108294.","journal-title":"Exp Eye Res"},{"issue":"02","key":"2757_CR3","first-page":"86","volume":"35","author":"X Xili","year":"2019","unstructured":"Xili X, Yuxiao N, Jie C. Research on dry eye in China in recent 10 years: a visual analysis based on Citespace. J Otolaryngol Shandong Univ. 2019;35(02):86\u201397.","journal-title":"J Otolaryngol Shandong Univ"},{"issue":"4","key":"2757_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/imm.13163","volume":"159","author":"DC Y\u00e1nez","year":"2020","unstructured":"Y\u00e1nez DC, Ross S, Crompton T. The IFITM protein family in adaptive immunity. Immunology. 2020;159(4):365\u201372.","journal-title":"Immunology"},{"issue":"6","key":"2757_CR5","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/abbs\/gmp034","volume":"41","author":"Y Xu","year":"2009","unstructured":"Xu Y, Yang G, Hu G. Binding of IFITM1 enhances the inhibiting effect of caveolin-1 on ERK activation. Acta Biochim Biophys Sin. 2009;41(6):488\u201394.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"4","key":"2757_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s40291-020-00469-4","volume":"24","author":"R Liang","year":"2020","unstructured":"Liang R, Li X, Zhu X. Deciphering the roles of IFITM1 in tumors. Mol Diagn Ther. 2020;24(4):433\u201341.","journal-title":"Mol Diagn Ther"},{"key":"2757_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev-virology-031413-085537","volume":"1","author":"CC Bailey","year":"2014","unstructured":"Bailey CC, et al. IFITM-family proteins: the cell\u2019s first line of antiviral defense. Annu Rev Virol. 2014;1:261\u201383.","journal-title":"Annu Rev Virol"},{"key":"2757_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.canlet.2021.05.006","volume":"514","author":"OK Provance","year":"2021","unstructured":"Provance OK, et al. Disrupting interferon-alpha and NF-kappaB crosstalk suppresses IFITM1 expression attenuating triple-negative breast cancer progression. Cancer Lett. 2021;514:12\u201329.","journal-title":"Cancer Lett"},{"key":"2757_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.702755","volume":"12","author":"CS de Paiva","year":"2021","unstructured":"de Paiva CS, et al. Differentially expressed gene pathways in the conjunctiva of Sj\u00f6gren syndrome keratoconjunctivitis sicca. Front Immunol. 2021;12: 702755.","journal-title":"Front Immunol"},{"key":"2757_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110853","volume":"132","author":"A Safa","year":"2020","unstructured":"Safa A, et al. MicroRNAs as regulators of ERK\/MAPK pathway: a comprehensive review. Biomed Pharmacother. 2020;132: 110853.","journal-title":"Biomed Pharmacother"},{"issue":"19","key":"2757_CR11","doi-asserted-by":"publisher","first-page":"16733","DOI":"10.1074\/jbc.M112483200","volume":"277","author":"MK Abe","year":"2002","unstructured":"Abe MK, et al. ERK8, a new member of the mitogen-activated protein kinase family. J Biol Chem. 2002;277(19):16733\u201343.","journal-title":"J Biol Chem"},{"issue":"3","key":"2757_CR12","first-page":"1997","volume":"19","author":"YJ Guo","year":"2020","unstructured":"Guo YJ, et al. ERK\/MAPK signalling pathway and tumorigenesis. Exp Ther Med. 2020;19(3):1997\u20132007.","journal-title":"Exp Ther Med"},{"key":"2757_CR13","doi-asserted-by":"publisher","first-page":"18619","DOI":"10.1038\/srep18619","volume":"5","author":"Y Ru","year":"2015","unstructured":"Ru Y, et al. \u03b1-Melanocyte-stimulating hormone ameliorates ocular surface dysfunctions and lesions in a scopolamine-induced dry eye model via PKA-CREB and MEK-Erk pathways. Sci Rep. 2015;5:18619.","journal-title":"Sci Rep"},{"issue":"10","key":"2757_CR14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/vim.2014.0028","volume":"27","author":"M Marku\u0161i\u0107","year":"2014","unstructured":"Marku\u0161i\u0107 M, et al. Induction of IFN-\u03b1 subtypes and their antiviral activity in mumps virus infection. Viral Immunol. 2014;27(10):497\u2013505.","journal-title":"Viral Immunol"},{"key":"2757_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/570909","volume":"2013","author":"XX Wan","year":"2013","unstructured":"Wan XX, et al. ISG15 inhibits IFN-\u03b1-resistant liver cancer cell growth. Biomed Res Int. 2013;2013: 570909.","journal-title":"Biomed Res Int"},{"issue":"1","key":"2757_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00262-004-0549-1","volume":"54","author":"P Tagliaferri","year":"2005","unstructured":"Tagliaferri P, et al. New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-alpha) treatment of human cancer. Cancer Immunol Immunother. 2005;54(1):1\u201310.","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"2757_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jaut.2010.06.012","volume":"35","author":"CP Mavragani","year":"2010","unstructured":"Mavragani CP, Crow MK. Activation of the type I interferon pathway in primary Sjogren\u2019s syndrome. J Autoimmun. 2010;35(3):225\u201331.","journal-title":"J Autoimmun"},{"issue":"7","key":"2757_CR18","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3390\/genes11070760","volume":"11","author":"R Vishnubalaji","year":"2020","unstructured":"Vishnubalaji R, Shaath H, Alajez NM. Protein coding and long noncoding RNA (lncRNA) transcriptional landscape in SARS-CoV-2 infected bronchial epithelial cells highlight a role for interferon and inflammatory response. Genes. 2020;11(7):760.","journal-title":"Genes"},{"issue":"12","key":"2757_CR19","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1097\/ICO.0000000000002495","volume":"39","author":"R Shetty","year":"2020","unstructured":"Shetty R, et al. Resveratrol rescues human corneal epithelial cells cultured in hyperosmolar conditions: potential for dry eye disease treatment. Cornea. 2020;39(12):1520\u201332.","journal-title":"Cornea"},{"issue":"7","key":"2757_CR20","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1167\/iovs.19-26914","volume":"60","author":"P Khamar","year":"2019","unstructured":"Khamar P, et al. Dysregulated tear fluid nociception-associated factors, corneal dendritic cell density, and vitamin D levels in evaporative dry eye. Invest Ophthalmol Vis Sci. 2019;60(7):2532\u201342.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"2757_CR21","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/eye.2017.289","volume":"32","author":"RJ Buckley","year":"2018","unstructured":"Buckley RJ. Assessment and management of dry eye disease. Eye. 2018;32(2):200\u20133.","journal-title":"Eye"},{"issue":"1","key":"2757_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12964-021-00756-5","volume":"19","author":"X Meng","year":"2021","unstructured":"Meng X, et al. PML-II regulates ERK and AKT signal activation and IFN\u03b1-induced cell death. Cell Commun Signal. 2021;19(1):70.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"2757_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cellimm.2010.02.012","volume":"263","author":"G Badr","year":"2010","unstructured":"Badr G, et al. Type I interferon (IFN-alpha\/beta) rescues B-lymphocytes from apoptosis via PI3Kdelta\/Akt, Rho-A, NFkappaB and Bcl-2\/Bcl(XL). Cell Immunol. 2010;263(1):31\u201340.","journal-title":"Cell Immunol"},{"issue":"3","key":"2757_CR24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3109\/08916930903510880","volume":"43","author":"P Rizza","year":"2010","unstructured":"Rizza P, Moretti F, Belardelli F. Recent advances on the immunomodulatory effects of IFN-alpha: implications for cancer immunotherapy and autoimmunity. Autoimmunity. 2010;43(3):204\u20139.","journal-title":"Autoimmunity"},{"issue":"6\u20137","key":"2757_CR25","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.biochi.2007.04.006","volume":"89","author":"M Ferrantini","year":"2007","unstructured":"Ferrantini M, Capone I, Belardelli F. Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use. Biochimie. 2007;89(6\u20137):884\u201393.","journal-title":"Biochimie"},{"issue":"4","key":"2757_CR26","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/sj.onc.1208204","volume":"24","author":"C Porta","year":"2005","unstructured":"Porta C, et al. Interferons alpha and gamma induce p53-dependent and p53-independent apoptosis, respectively. Oncogene. 2005;24(4):605\u201315.","journal-title":"Oncogene"},{"issue":"5 Suppl 16","key":"2757_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1053\/j.seminoncol.2003.08.015","volume":"30","author":"S Wang","year":"2003","unstructured":"Wang S, Yang D, Lippman ME. Targeting Bcl-2 and Bcl-XL with nonpeptidic small-molecule antagonists. Semin Oncol. 2003;30(5 Suppl 16):133\u201342.","journal-title":"Semin Oncol"},{"issue":"29","key":"2757_CR28","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1038\/sj.onc.1206503","volume":"22","author":"T Panaretakis","year":"2003","unstructured":"Panaretakis T, et al. Interferon-alpha-induced apoptosis in U266 cells is associated with activation of the proapoptotic Bcl-2 family members Bak and Bax. Oncogene. 2003;22(29):4543\u201356.","journal-title":"Oncogene"},{"issue":"2","key":"2757_CR29","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1365-2141.1994.tb05017.x","volume":"88","author":"AP Jewell","year":"1994","unstructured":"Jewell AP, et al. Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo. Br J Haematol. 1994;88(2):268\u201374.","journal-title":"Br J Haematol"},{"issue":"5","key":"2757_CR30","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3390\/v11050427","volume":"11","author":"T Li","year":"2019","unstructured":"Li T, et al. Human hepatitis B virus core protein inhibits IFN\u03b1-induced IFITM1 expression by interacting with BAF200. Viruses. 2019;11(5):427.","journal-title":"Viruses"},{"issue":"20","key":"2757_CR31","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.3390\/cancers13205130","volume":"13","author":"TE Escher","year":"2021","unstructured":"Escher TE, et al. Enhanced IFN\u03b1 signaling promotes ligand-independent activation of ER\u03b1 to promote aromatase inhibitor resistance in breast cancer. Cancers. 2021;13(20):5130.","journal-title":"Cancers"},{"key":"2757_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/821940","volume":"2010","author":"JY Kim","year":"2010","unstructured":"Kim JY, et al. Activation of CD147 with cyclophilin a induces the expression of IFITM1 through ERK and PI3K in THP-1 cells. Mediators Inflamm. 2010;2010: 821940.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"2757_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1167\/iovs.11-8553","volume":"53","author":"X Xiao","year":"2012","unstructured":"Xiao X, et al. Therapeutic effects of epidermal growth factor on benzalkonium chloride-induced dry eye in a mouse model. Invest Ophthalmol Vis Sci. 2012;53(1):191\u20137.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02757-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02757-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02757-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T01:55:28Z","timestamp":1751853328000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02757-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2757"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02757-3","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the ethical guidelines for research involving biological samples and complied with the Declaration of Helsinki and applicable ethical standards. Consent to participate is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"582"}}